FTV — Fortive Corporation

Fortive Corporation (FTV) Q1 2026 Earnings Call Summary

1. Key Financial Results and Metrics

• Total Revenue: Approximately $1.1 billion, up nearly 8% year-over-year; core revenue growth of just over 5%.
• Adjusted EBITDA: $314 million, reflecting a 13% increase year-over-year; adjusted EBITDA margin expanded to over 29%.
• Adjusted EPS: $0.70, up over 25% year-over-year, marking the third consecutive quarter of double-digit EPS growth.
• Free Cash Flow: Generated $194 million in Q1, with a trailing twelve-month free cash flow conversion exceeding 100%.
• Share Repurchases: Approximately $500 million in share repurchases completed in Q1, reducing share count by over 10% since July 2025.

2. Strategic Updates and Business Highlights

• Fortive Accelerator Strategy: Continued focus on three pillars: organic growth, disciplined capital allocation, and maintaining investor trust.
• Product Innovations: Successful launches in the data center segment (e.g., CertiFiber Max) and AI-driven healthcare solutions (e.g., Provation Mirror Documentation Assist).
• Recurring Revenue Growth: Strong performance in recurring revenue initiatives, with double-digit services growth at Fluke and robust growth in hardware-as-a-service offerings.
• Geographic Performance: Solid growth in North America; Europe showed sequential improvement.

3. Forward Guidance and Outlook

• Full-Year Adjusted EPS Guidance: Reaffirmed at $2.90 to $3.00 per share, with expectations trending towards the upper half of this range.
• Revenue Expectations: Projected full-year revenue around $4.3 billion, with core growth anticipated in the 2% to 3% range.
• Q2 Expectations: Anticipated EPS and margins to be broadly similar to Q1, with some challenges due to fewer selling days in Q4.

4. Challenges and Points of Concern

• Gross Margin Pressure: Adjusted gross margin decreased slightly year-over-year, impacted by tariffs and product mix.
• Hospital CapEx Pressures: Ongoing caution in capital spending from hospitals, particularly in North America, although some improvement is noted.
• Tariff Headwinds: Continued impact from tariffs expected to affect gross margins until countermeasures are fully implemented by Q3.

5. Notable Q&A Insights

• Order Strength: Orders grew faster than revenue, indicating positive demand trends across segments, particularly in Fluke and Advanced Healthcare Solutions (AHS).
• AI Integration: AI-driven innovations are seen as a growth driver, with successful integration into existing product lines.
• M&A Outlook: Focus on bolt-on acquisitions with a revamped M&A strategy; new leadership in corporate development expected to enhance efforts.
• Data Center Opportunities: Strong demand anticipated in the data center market, with Fluke positioned to benefit from ongoing operational needs and new technologies.
• Market Dynamics: Analysts expressed concerns about potential earnings moderation in Q2, but management indicated confidence in the business momentum and execution of strategic initiatives.

This summary encapsulates Fortive Corporation's financial performance, strategic direction, and market outlook as discussed in the Q1 2026 earnings call, highlighting both achievements and challenges faced by the company.